# L-arginine in Treatment as Usual in Schizophrenia

> **NCT00718510** · NA · COMPLETED · sponsor: **University of Alberta** · enrollment: 13 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** L-Arginine

## Key facts

- **NCT ID:** NCT00718510
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-07
- **Final completion:** 2012-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718510, "L-arginine in Treatment as Usual in Schizophrenia". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00718510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*